ProfileGDS5822 / ILMN_1236387
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 83% 90% 86% 83% 89% 86% 88% 87% 89% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 1197.883
GSM1276600PDAC Late Ablation Control 2468.590
GSM1276601PDAC Late Ablation Control 3354.986
GSM1276602PDAC Late Ablation 1207.283
GSM1276603PDAC Late Ablation 2450.189
GSM1276604PDAC Late Ablation 3303.986
GSM1303940PDAC Late Ablation_anti-CTLA4 1377.888
GSM1303941PDAC Late Ablation_anti-CTLA4 2404.187
GSM1303942PDAC Late Ablation_anti-CTLA4 3508.589